S74

Sông Đà 7.04 ·UPCOM ·2021Q1

▲▲ Improving positively

The balance sheet remains flexible Debt/equity −0.00x
Price
16,300
Latest close
02 Jun 2026
P/E
P/B 0.91x
EPS
BVPS 17,932
ROE 14.4%
ROA 11.9%
Profit Margin 71.0%
Asset Turnover 0.17x
Equity Mult. 1.22x

TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity

What Is Changing

On a Năm 2025 basis, S74 is improving on both revenue and margins, suggesting current growth is backed by both scale and operating efficiency — the growth momentum has held across consecutive periods. The next test will be whether this pace holds as the comparison base gets tougher.

TTM REVENUE
VND 42bn
+505.6%YoY
NET MARGIN
71.01%
+120.2ppYoY
TTM NET PROFIT
VND 30bn
+974.3%YoY
Metric Q1'21
Revenue 0.0
Growth
Net Income -0.4
Net Margin -1199.93%

Financial Highlights

Detailed analysis of each financial dimension

Is the profit sustainable?

Margins are broadly flat — earnings quality is the factor to watch.

very positive positive stable watch under pressure

What is driving the margin?

Track net margin changes and the operating components against the same period last year.

Profitability trend

Net Margin 71.01% +120.2pp
Gross Margin
SG&A / Revenue

Is capital being used efficiently?

Evaluate capital, asset, and working-capital efficiency.

Balance Sheet

Balance sheet is exceptionally sound — liabilities at 0.35x equity, with a net cash position equivalent to 0.00x equity.

Over the last 12 months, working capital released 0.0bn of cash.

Working Capital Drivers

TTM YoY · Prior -> 2021Q1

Receivables were broadly stable → neutral CFO:
Inventories were broadly stable → neutral CFO:
Payables were broadly stable → neutral CFO:

Working Capital Efficiency

Track receivable, inventory, and payable turns to judge working-capital efficiency.

Track DSO, DIO, DPO components to evaluate working capital turnover efficiency.

Working Capital Efficiency

TTM YoY · Prior -> 2021Q1

Receivables
Inventory
Payables
Cash Conversion Cycle

Is financial risk significant?

Check leverage, liquidity, and cash-flow conversion.

Leverage & Liquidity

Track net leverage, interest coverage, and the liquidity buffer on the balance sheet.

At present, total debt stands at 0.0bn.

Some leverage signals are missing, so the current read should be treated as contextual.

Leverage and liquidity trend

Net Debt / Equity -0.00x
Interest Coverage
Cash / Debt
Short-term Debt / Total Debt

TTM YoY · Prior -> 2021Q1

Investment Takeaway

The business is showing brightening signals, but the improvement is still early and not yet thick enough to read as a confirmed trend. The brighter spot is balance-sheet flexibility, with net cash/equity at about -0.00x. The next item to monitor is capital structure should be read with cycle risk in mind.

Improvement: the balance sheet remains flexible, with a net cash position equivalent to 0.00x of equity.

Watchpoint: Capital structure should be read with cycle risk in mind.

Statement Data

Item 2025 2024 2023 2022 2021
Net Revenue
42.5 7.0 0.0 10.6 0.0
Cost of Goods Sold
42.2 8.2 0.0 10.8 0.0
Gross Profit
0.3 -1.1 0.0 -0.2 0.0
Financial Expenses
1.0 0.0 0.0 -5.5 0.0
Selling Expenses
0.0 0.0 0.0 0.0
General and Administrative Expenses
2.8 3.3 4.3 2.0 -0.4
Operating Profit
30.2 -3.3 49.7 5.6 -0.4
Profit Before Tax
30.2 -3.3 49.1 5.6 -0.4
Net Income
30.2 -3.5 49.1 5.6 -0.4
Profit Attributable to Parent
30.2 -3.5 49.1 5.6 -0.4
Earnings per Share
4,657.00 -533.00 7,572.00 866.00 -55.00

Explore Other Stocks In The Same Sector

VCS, VLB, HT1, MVC, THG, KSB, NNC, LBM, FIC, DHA, LIC, BMJ, HUB, VIT, MTA, TLD, SCL, PDB, CVT, MDG, CLH, RYG, QNC, BTS, CMD, HCC, VHL, PCC, YBM, VCX, CCM, C32, BCC, GND, HOM, TRT, TLT, BTD, TNT, FCM, GMH, GMX, ACE, KHD, SCJ, VIH, CDG, CQT, BDT, YBC, AMC, SDY, KSQ, NHC, EME, TMX, TAB, XMD, TDF, DDB, DAC, MCC, HMR, TTC, NXT, DID, TCR, DIC, MIC, VIM, DXV, VTS, HPM, TXM, SCC, DCR, DKG, LMC, GKM, BHC, TTZ, X77, LQN, VHH, SPI, BTN, HLY, DGT, VTA, CMI, DTC, DND, ILA, CYC, LCC, PTE, HVX, BT6, DCT, CTA, KHL, PX1

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.